| RS374670754 |
MYOM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Abnormality of the liver, Hypoglycemia |
| RS374670875 |
ARHGEF10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS374672041 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS374672276 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
CBL-related disorder, RASopathy |
| RS374672630 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS374672854 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS374672916 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS374673302 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS374673335 |
GLE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lethal congenital contracture syndrome 1, Lethal arthrogryposis-anterior horn cell disease syndrome |
| RS374673391 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 1A (Zellweger), Zellweger spectrum disorders |
| RS374673836 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS374673921 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, AP5Z1-related disorder |
| RS374673974 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS374674165 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS374675648 |
HTRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Macular degeneration, Macular degeneration |
| RS374677022 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Congenital myopathy |
| RS374677194 |
SERPINF1
|
Health Risk |
Pathogenic |
— |
| RS374677519 |
B3GALT6
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, spondylodysplastic type |
| RS374680668 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS374681194 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Ceroid lipofuscinosis, neuronal |
| RS374681570 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Cardiovascular phenotype |
| RS374682222 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS374682395 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS374683078 |
HCFC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Methylmalonic acidemia with homocystinuria |
| RS374683153 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS374683235 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS374684032 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS374685631 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS374685632 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS374685908 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder 1 |
| RS374686347 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS374686479 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Migraine |
| RS374686904 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS374687883 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS374688294 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS374688464 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS374688634 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS374689398 |
HPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome 1 |
| RS374689888 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 69 |
| RS374690853 |
EFEMP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Doyne honeycomb retinal dystrophy, Doyne honeycomb retinal dystrophy |
| RS374690894 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 4, Nephronophthisis |
| RS374690916 |
RAB3GAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Martsolf syndrome, Warburg micro syndrome 2 |
| RS374691049 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS374691153 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Gorlin syndrome |
| RS374691339 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS374691587 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS374692105 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachydactyly type B1, Autosomal recessive Robinow syndrome |
| RS374692260 |
PDE8B
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant striatal neurodegeneration type 1, Autosomal dominant striatal neurodegeneration type 1 |
| RS374692915 |
SLC26A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Atelosteogenesis type II, Sulfate transporter-related osteochondrodysplasia |
| RS374693929 |
MYO18B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS374694909 |
HSPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS374695099 |
ASXL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS374695194 |
CUBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS374697328 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS374697567 |
SGCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoclonic dystonia 11, Inborn genetic diseases |
| RS374698153 |
PNPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 13, Inborn genetic diseases |
| RS374698559 |
CNNM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS374698863 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, COL7A1-related disorder |
| RS374699130 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS374699716 |
IL12RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS374700234 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS374700658 |
HOXD10
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital vertical talus, Congenital vertical talus |
| RS374701055 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Intellectual disability |
| RS374701109 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, ABCB11-related disorder |
| RS374701362 |
GJA3
|
Health Risk |
Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS374702278 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS374702599 |
SLC2A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi-Bickel syndrome, SLC2A2-related disorder |
| RS374703179 |
CIITA
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, Inborn genetic diseases |
| RS374703898 |
CSPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS374704368 |
PIGN
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS374704486 |
DNAAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS374704824 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS374705585 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS374705823 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS374707420 |
ITGA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS374707462 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiomyopathy |
| RS374707677 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS374708033 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-Related Spectrum Disorders |
| RS374709083 |
RYR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS374709193 |
TRAPPC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 13 |
| RS374709763 |
COASY
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 6, COASY-Related Disorders |
| RS374710242 |
POP1
|
Health Risk |
Pathogenic |
— |
| RS374712231 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS374712759 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex, Ogna type |
| RS3747131 |
HPS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS374713901 |
C4B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS374713915 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS374714172 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
ANKRD11-related disorder, KBG syndrome |
| RS374714909 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 25 |
| RS374715276 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS374716181 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS374716369 |
KIDINS220
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spastic paraplegia |
| RS374717754 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome |
| RS374718437 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS374718674 |
INPP5E
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome 1 |
| RS374718902 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, COL7A1-related disorder |
| RS374719323 |
PLD1
|
Health Risk |
Likely pathogenic |
Cardiac valvular defect, developmental |
| RS374720181 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, Inborn genetic diseases |
| RS374720207 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS374720304 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |